TIMI risk score

Does it work equally well in both male and females?

Marianna Karounos, Anna Marie Chang, Jennifer L. Robey, Keara L. Sease, Frances S. Shofer, Christopher Follansbee, Judd E. Hollander

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: The TIMI (Thrombolysis In Myocardial Infarction) risk score is a seven item risk stratification tool derived from trials of patients with non-ST segment elevation acute coronary syndromes (ACS) that has been validated in emergency department (ED) patients with potential ACS. We hypothesised that it might have different prognostic abilities in male and female patients. Methods: This was a prospective cohort study of ED patients with potential ACS. Data included demographics, medical and cardiac history, and components of the TIMI risk score. Investigators followed the hospital course daily. The main outcome was death, acute myocardial infarction (AMI), or revascularisation within 30 days as stratified by TIMI risk score and compared between genders using χ2 tests. Results: There were 2022 patients enrolled: 1204 (60%) females and 818 (40%) males. The incidence of 30 day death, AMI, revascularisation (n=168) according to TIMI score is as follows (female vs male): TIMI 0 (n=670), 1.6% vs 2.0%, p=0.2; TIMI 1 (n=525), 4.6% vs 8.5%, p=0.02; TIMI 2 (n=378), 6.3% vs 10.4%, p=0.05; TIMI 3 (n=234), 6.5% vs 24.6%, p

Original languageEnglish (US)
Pages (from-to)471-474
Number of pages4
JournalEmergency Medicine Journal
Volume24
Issue number7
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Myocardial Infarction
Acute Coronary Syndrome
Myocardial Revascularization
Hospital Emergency Service
Cohort Studies
History
Research Personnel
Demography
Prospective Studies
Incidence

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Surgery
  • Nursing(all)
  • Emergency Medicine

Cite this

Karounos, M., Chang, A. M., Robey, J. L., Sease, K. L., Shofer, F. S., Follansbee, C., & Hollander, J. E. (2007). TIMI risk score: Does it work equally well in both male and females? Emergency Medicine Journal, 24(7), 471-474. https://doi.org/10.1136/emj.2007.048207

TIMI risk score : Does it work equally well in both male and females? / Karounos, Marianna; Chang, Anna Marie; Robey, Jennifer L.; Sease, Keara L.; Shofer, Frances S.; Follansbee, Christopher; Hollander, Judd E.

In: Emergency Medicine Journal, Vol. 24, No. 7, 07.2007, p. 471-474.

Research output: Contribution to journalArticle

Karounos, M, Chang, AM, Robey, JL, Sease, KL, Shofer, FS, Follansbee, C & Hollander, JE 2007, 'TIMI risk score: Does it work equally well in both male and females?', Emergency Medicine Journal, vol. 24, no. 7, pp. 471-474. https://doi.org/10.1136/emj.2007.048207
Karounos M, Chang AM, Robey JL, Sease KL, Shofer FS, Follansbee C et al. TIMI risk score: Does it work equally well in both male and females? Emergency Medicine Journal. 2007 Jul;24(7):471-474. https://doi.org/10.1136/emj.2007.048207
Karounos, Marianna ; Chang, Anna Marie ; Robey, Jennifer L. ; Sease, Keara L. ; Shofer, Frances S. ; Follansbee, Christopher ; Hollander, Judd E. / TIMI risk score : Does it work equally well in both male and females?. In: Emergency Medicine Journal. 2007 ; Vol. 24, No. 7. pp. 471-474.
@article{8fdb56da506b4c27aacf2915c4442eff,
title = "TIMI risk score: Does it work equally well in both male and females?",
abstract = "Objective: The TIMI (Thrombolysis In Myocardial Infarction) risk score is a seven item risk stratification tool derived from trials of patients with non-ST segment elevation acute coronary syndromes (ACS) that has been validated in emergency department (ED) patients with potential ACS. We hypothesised that it might have different prognostic abilities in male and female patients. Methods: This was a prospective cohort study of ED patients with potential ACS. Data included demographics, medical and cardiac history, and components of the TIMI risk score. Investigators followed the hospital course daily. The main outcome was death, acute myocardial infarction (AMI), or revascularisation within 30 days as stratified by TIMI risk score and compared between genders using χ2 tests. Results: There were 2022 patients enrolled: 1204 (60{\%}) females and 818 (40{\%}) males. The incidence of 30 day death, AMI, revascularisation (n=168) according to TIMI score is as follows (female vs male): TIMI 0 (n=670), 1.6{\%} vs 2.0{\%}, p=0.2; TIMI 1 (n=525), 4.6{\%} vs 8.5{\%}, p=0.02; TIMI 2 (n=378), 6.3{\%} vs 10.4{\%}, p=0.05; TIMI 3 (n=234), 6.5{\%} vs 24.6{\%}, p",
author = "Marianna Karounos and Chang, {Anna Marie} and Robey, {Jennifer L.} and Sease, {Keara L.} and Shofer, {Frances S.} and Christopher Follansbee and Hollander, {Judd E.}",
year = "2007",
month = "7",
doi = "10.1136/emj.2007.048207",
language = "English (US)",
volume = "24",
pages = "471--474",
journal = "Emergency Medicine Journal",
issn = "1472-0205",
publisher = "BMJ Publishing Group",
number = "7",

}

TY - JOUR

T1 - TIMI risk score

T2 - Does it work equally well in both male and females?

AU - Karounos, Marianna

AU - Chang, Anna Marie

AU - Robey, Jennifer L.

AU - Sease, Keara L.

AU - Shofer, Frances S.

AU - Follansbee, Christopher

AU - Hollander, Judd E.

PY - 2007/7

Y1 - 2007/7

N2 - Objective: The TIMI (Thrombolysis In Myocardial Infarction) risk score is a seven item risk stratification tool derived from trials of patients with non-ST segment elevation acute coronary syndromes (ACS) that has been validated in emergency department (ED) patients with potential ACS. We hypothesised that it might have different prognostic abilities in male and female patients. Methods: This was a prospective cohort study of ED patients with potential ACS. Data included demographics, medical and cardiac history, and components of the TIMI risk score. Investigators followed the hospital course daily. The main outcome was death, acute myocardial infarction (AMI), or revascularisation within 30 days as stratified by TIMI risk score and compared between genders using χ2 tests. Results: There were 2022 patients enrolled: 1204 (60%) females and 818 (40%) males. The incidence of 30 day death, AMI, revascularisation (n=168) according to TIMI score is as follows (female vs male): TIMI 0 (n=670), 1.6% vs 2.0%, p=0.2; TIMI 1 (n=525), 4.6% vs 8.5%, p=0.02; TIMI 2 (n=378), 6.3% vs 10.4%, p=0.05; TIMI 3 (n=234), 6.5% vs 24.6%, p

AB - Objective: The TIMI (Thrombolysis In Myocardial Infarction) risk score is a seven item risk stratification tool derived from trials of patients with non-ST segment elevation acute coronary syndromes (ACS) that has been validated in emergency department (ED) patients with potential ACS. We hypothesised that it might have different prognostic abilities in male and female patients. Methods: This was a prospective cohort study of ED patients with potential ACS. Data included demographics, medical and cardiac history, and components of the TIMI risk score. Investigators followed the hospital course daily. The main outcome was death, acute myocardial infarction (AMI), or revascularisation within 30 days as stratified by TIMI risk score and compared between genders using χ2 tests. Results: There were 2022 patients enrolled: 1204 (60%) females and 818 (40%) males. The incidence of 30 day death, AMI, revascularisation (n=168) according to TIMI score is as follows (female vs male): TIMI 0 (n=670), 1.6% vs 2.0%, p=0.2; TIMI 1 (n=525), 4.6% vs 8.5%, p=0.02; TIMI 2 (n=378), 6.3% vs 10.4%, p=0.05; TIMI 3 (n=234), 6.5% vs 24.6%, p

UR - http://www.scopus.com/inward/record.url?scp=34447124399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447124399&partnerID=8YFLogxK

U2 - 10.1136/emj.2007.048207

DO - 10.1136/emj.2007.048207

M3 - Article

VL - 24

SP - 471

EP - 474

JO - Emergency Medicine Journal

JF - Emergency Medicine Journal

SN - 1472-0205

IS - 7

ER -